Viewing Study NCT05201404


Ignite Creation Date: 2025-12-24 @ 7:58 PM
Ignite Modification Date: 2025-12-25 @ 5:32 PM
Study NCT ID: NCT05201404
Status: RECRUITING
Last Update Posted: 2025-04-29
First Post: 2021-12-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Sponsor: Can-Fite BioPharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module